Vancomycin Plus Piperacillin–Tazobactam Versus Vancomycin Plus Cefepime and the Risk of Acute Kidney Injury in Hospitalised Adults: A Meta-Analysis
Sriwijaya Journal of Internal Medicine · 03.06.2026 · 4 (1) · 30-38
DOI: 10.59345/sjim.v4i1.267 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Sriwijaya Journal of Internal Medicine, online erschienen am 03.06.2026. Verfasst von Putri Indah Permata und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Background
The combination of vancomycin and piperacillin–tazobactam is among the most frequently prescribed empirical regimens for serious infections, yet observational data suggest that it may increase the risk of acute kidney injury (AKI). Because vancomycin is common to many comparisons, the cleanest test of the piperacillin–tazobactam effect is a head-to-head comparison against vancomycin plus cefepime, in which vancomycin exposure is held constant. This meta-analysis quantified the association between the two regimens and AKI in hospitalised adults.
Methods
PubMed/MEDLINE, Scopus and Web of Science were searched for comparative cohort studies and randomised trials in adults reporting AKI with vancomycin plus piperacillin–tazobactam versus vancomycin plus cefepime. Two regimens were compared. Risk of bias was appraised with ROBINS-I. Odds ratios (OR) were pooled using a DerSimonian–Laird random-effects model; heterogeneity was summarised with the I² statistic, and small-study effects were examined with the Egger test and a leave-one-out sensitivity analysis.
Results
Ten cohort studies were eligible and nine contributed to the quantitative synthesis. Vancomycin plus piperacillin–tazobactam was associated with significantly higher odds of AKI than vancomycin plus cefepime (pooled OR 1.90, 95% CI 1.43–2.52; p
Zitieren
APA
Permata, P. I., & Viotra, D. (2026). Vancomycin Plus Piperacillin–Tazobactam Versus Vancomycin Plus Cefepime and the Risk of Acute Kidney Injury in Hospitalised Adults: A Meta-Analysis. Sriwijaya Journal of Internal Medicine, 4(1), 30-38. https://doi.org/10.59345/sjim.v4i1.267
Vancouver
Permata PI, Viotra D. Vancomycin Plus Piperacillin–Tazobactam Versus Vancomycin Plus Cefepime and the Risk of Acute Kidney Injury in Hospitalised Adults: A Meta-Analysis. Sriwijaya Journal of Internal Medicine. 2026;4(1):30-38. doi:10.59345/sjim.v4i1.267
BibTeX
@article{Permata2026,
author = {Permata, Putri Indah and Viotra, Deka},
title = {Vancomycin Plus Piperacillin–Tazobactam Versus Vancomycin Plus Cefepime and the Risk of Acute Kidney Injury in Hospitalised Adults: A Meta-Analysis},
journal = {Sriwijaya Journal of Internal Medicine},
year = {2026},
volume = {4},
number = {1},
pages = {30--38},
doi = {10.59345/sjim.v4i1.267}
}
EUVIMED